Highlights: Omega Healthcare Investors, Inc.

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Analyst opinion has improved significantly over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses: Omega Healthcare Investors, Inc.

  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • With a 2024 P/E ratio at 25.11 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The group usually releases earnings worse than estimated.

Ratings Chart: Omega Healthcare Investors, Inc.

surperformance-ratings-chart OMEGA-HEALTHCARE-INVESTOR
Source: Surperformance

ESG chart: Omega Healthcare Investors, Inc.

esg-ratings-chart OMEGA-HEALTHCARE-INVESTOR
Source: MSCI

Add to a list
Composite Fundamentals Composite Valuation Composite Momentum Capi. ($)
10.09B
80.54B
24.71B
14.53B
5.81B
5.01B
4.27B
4.01B
3.15B
2.98B
Average 15.51B
Weighted average by Cap.
See all sector ratings
Investor Rating
Trading Rating
ESG MSCI
BBB

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

ESG

Environment
Social
Governance
Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. OHI Stock
  4. Ratings Omega Healthcare Investors, Inc.